Standout Papers

Association of Glucagon-Like Peptide-1 Receptor Agonist Use With Risk of Gallbladder and Biliary Diseases 2022 2026 2023 2024144
  1. Association of Glucagon-Like Peptide-1 Receptor Agonist Use With Risk of Gallbladder and Biliary Diseases (2022)
    Liyun He, Jialu Wang et al. JAMA Internal Medicine

Immediate Impact

1 from Science/Nature 67 standout
Sub-graph 1 of 22

Citing Papers

Efficacy and Safety of Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss Among Adults Without Diabetes
2025 Standout
Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity
2025 Standout
1 intermediate paper

Works of Liyun He being referenced

Association of Glucagon-Like Peptide-1 Receptor Agonist Use With Risk of Gallbladder and Biliary Diseases
2022 Standout

Author Peers

Author Last Decade Papers Cites
Liyun He 168 132 27 123 47 635
A. Cournot 89 81 129 83 30 700
Jean‐Pierre Garnier 111 201 53 102 37 739
Jongoh Kim 206 89 65 57 25 591
Li Zhou 44 85 26 175 66 630
Bingbing Fan 54 119 66 203 44 693
Alessandra Bosetti 160 140 49 76 41 686
Lucjan Pawlicki 72 80 183 91 63 629
Douglas Gause 191 66 55 52 20 710
Yosefa Bar Dayan 94 54 13 94 23 649
Mamoru Tanaka 43 139 55 113 65 684

All Works

Loading papers...

Rankless by CCL
2026